STOCK TITAN

Scientist Home Future Health Financials

SHFH
Source SEC Filings (10-K/10-Q) Updated Mar 27, 2026 Currency USD FYE March

This page shows Scientist Home Future Health (SHFH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 4 / 100
Financial Profile 4/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
0

Scientist Home Future Health has an operating margin of -113.6%, meaning the company retains $-114 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses.

Leverage
6

Scientist Home Future Health has elevated debt relative to equity (D/E of 4.68), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 6/100, reflecting increased financial risk.

Liquidity
13

Scientist Home Future Health's current ratio of 0.90 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 13/100, which could limit financial flexibility.

Cash Flow
0

While Scientist Home Future Health generated -$248K in operating cash flow, capex of $75K consumed most of it, leaving -$323K in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns
0

Scientist Home Future Health generates a -204.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100.

Earnings Quality Low Quality
1.07x

For every $1 of reported earnings, Scientist Home Future Health generates $1.07 in operating cash flow (-$248K OCF vs -$232K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$204K

Scientist Home Future Health generated $204K in revenue in fiscal year 2025.

EBITDA
-$230K

Scientist Home Future Health's EBITDA was -$230K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Net Income
-$232K

Scientist Home Future Health reported -$232K in net income in fiscal year 2025.

EPS (Diluted)
$-0.01

Scientist Home Future Health earned $-0.01 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$323K

Scientist Home Future Health generated -$323K in free cash flow in fiscal year 2025, representing cash available after capex.

Cash & Debt
$69K

Scientist Home Future Health held $69K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
24M

Scientist Home Future Health had 24M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
40.1%

Scientist Home Future Health's gross margin was 40.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.

Operating Margin
-113.6%

Scientist Home Future Health's operating margin was -113.6% in fiscal year 2025, reflecting core business profitability.

Net Margin
-113.6%

Scientist Home Future Health's net profit margin was -113.6% in fiscal year 2025, showing the share of revenue converted to profit.

Return on Equity
-204.4%

Scientist Home Future Health's ROE was -204.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$75K

Scientist Home Future Health invested $75K in capex in fiscal year 2025, funding long-term assets and infrastructure.

SHFH Income Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Revenue $40K+25.5% $32K-29.6% $45K N/A $59K
Cost of Revenue $24K+30.7% $18K-28.3% $25K N/A $33K
Gross Profit $16K+18.7% $14K-31.2% $20K N/A $26K
R&D Expenses N/A N/A N/A N/A N/A
SG&A Expenses $64K+23.7% $52K+307.1% $13K N/A $24K
Operating Income -$48K-25.4% -$38K-645.4% $7K N/A $2K
Interest Expense N/A N/A N/A N/A N/A
Income Tax $0+100.0% -$9350.0% -$935 N/A $2K
Net Income -$48K-28.6% -$37K-714.2% $6K N/A $175
EPS (Diluted) $0.00 $0.00 $0.00 N/A $0.00

SHFH Balance Sheet

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Total Assets $723K+530.3% $115K+485.4% $20K-7.8% $21K-54.2% $46K
Current Assets $326K+183.9% $115K+485.4% $20K-7.8% $21K N/A
Cash & Equivalents $276K+147.4% $111K+590.3% $16K-13.4% $19K-1.8% $19K
Inventory $2K-40.2% $3K-3.8% $3K+31.7% $3K N/A
Accounts Receivable N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A
Total Liabilities $456K+621.7% $63K+222.9% $20K-28.2% $27K-26.8% $37K
Current Liabilities $123K+95.3% $63K+222.9% $20K-28.2% $27K N/A
Long-Term Debt N/A N/A N/A N/A N/A
Total Equity $267K+418.1% $52K+190763.0% $27+100.4% -$6K-165.9% $9K
Retained Earnings -$94K-103.7% -$46K-417.1% -$9K+40.4% -$15K N/A

SHFH Cash Flow Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Operating Cash Flow -$99K-1776.6% -$5K-9.6% -$5K N/A -$9K
Capital Expenditures N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A
Financing Cash Flow $265K+163.9% $101K+4188.7% $2K N/A $28K
Dividends Paid N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A

SHFH Financial Ratios

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Gross Margin 40.6%-2.3pp 42.9%-1.0pp 43.9% N/A 44.5%
Operating Margin -120.8%+0.1pp -120.9%-136.5pp 15.6% N/A 3.3%
Net Margin -120.8%-2.9pp -117.9%-131.5pp 13.5% N/A 0.3%
Return on Equity -17.9%+54.3pp -72.2%-22513.0pp 22440.7% N/A 1.9%
Return on Assets -6.6%+25.8pp -32.4%-63.4pp 30.9% N/A 0.4%
Current Ratio 2.64+0.8 1.82+0.8 1.00+0.2 0.78 N/A
Debt-to-Equity 1.71+0.5 1.23-723.5 724.74+729.3 -4.53-8.6 4.08
FCF Margin N/A N/A N/A N/A N/A

Note: The current ratio is below 1.0 (0.90), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Scientist Home Future Health (SHFH) reported $204K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, Scientist Home Future Health (SHFH) reported a net income of -$232K in fiscal year 2025, with a net profit margin of -113.6%.

Scientist Home Future Health (SHFH) reported diluted earnings per share of $-0.01 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Scientist Home Future Health (SHFH) had EBITDA of -$230K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Scientist Home Future Health (SHFH) had a gross margin of 40.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Scientist Home Future Health (SHFH) had an operating margin of -113.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Scientist Home Future Health (SHFH) had a net profit margin of -113.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Scientist Home Future Health (SHFH) has a return on equity of -204.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Scientist Home Future Health (SHFH) generated -$323K in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Scientist Home Future Health (SHFH) generated -$248K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Scientist Home Future Health (SHFH) had $644K in total assets as of fiscal year 2025, including both current and long-term assets.

Scientist Home Future Health (SHFH) invested $75K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Scientist Home Future Health (SHFH) had 24M shares outstanding as of fiscal year 2025.

Scientist Home Future Health (SHFH) had a current ratio of 0.90 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Scientist Home Future Health (SHFH) had a debt-to-equity ratio of 4.68 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Scientist Home Future Health (SHFH) had a return on assets of -36.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Scientist Home Future Health (SHFH) had $69K in cash against an annual operating cash burn of $248K. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Scientist Home Future Health (SHFH) has an earnings quality ratio of 1.07x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Scientist Home Future Health (SHFH) scores 4 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top